Graviton Bioscience
New York
About Graviton Bioscience
Graviton Bioscience is a clinical-stage drug discovery and development firm focused on creating and developing therapies for the treatment of CNS, autoimmune, fibrotic, and other significant disorders in which ROCK2 plays a critical role in pathology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $64.8M
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2024)
- Website: gravitoncorp.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/graviton-bioscience-115379 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.